{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:17:01Z","timestamp":1789773421558,"version":"4.0.1"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>Aggressive B-cell lymphomas are a biologically and clinically very heterogeneous group of tumors that may be related to different stages of B-cell differentiation development. This review aims to summarize recent advances in the understanding of these tumors with a focus on the practical approach to the diagnosis of these entities. We analyze the defining characteristics of the different subtypes of aggressive B-cell lymphomas, including nodal and extranodal diffuse large B-cell lymphoma, virus-associated lymphomas, terminally differentiated B-cell lymphomas, high-grade B-cell lymphomas, and Burkitt lymphoma. This review particularly explores the integration of morphologic, immunophenotypic, and genetic data that refine diagnostic accuracy and prognostic stratification, underscoring the necessity for a standardized approach in clinical practice. By synthesizing current knowledge, this review aims to enhance the understanding of aggressive B-cell lymphomas within the context of the evolving classification system, paving the way for future research and clinical advancements.<\/jats:p>","DOI":"10.1097\/pap.0000000000000484","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T11:00:29Z","timestamp":1736938829000},"page":"208-219","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Advances in the Classification of Aggressive B-cell Lymphomas"],"prefix":"10.1097","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4236-5799","authenticated-orcid":false,"given":"Leonie","family":"Frauenfeld","sequence":"first","affiliation":[{"name":"Institut d\u2019Investigacions Biomediques August Pi i Sunyer (IDIBAPS)"},{"name":"Institute of Pathology and Neuropathology, Eberhard Karls University of Tubingen and Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biomediques August Pi i Sunyer (IDIBAPS)"},{"name":"Hematopathology Unit, Hospital Clin\u00edc de Barcelona, University of Barcelona, Barcelona"},{"name":"Centro de Investigacion Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"R1-20250414","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R2-20250414","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"R3-20250414","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00428-022-03466-6","article-title":"Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities","volume":"482","author":"Song","year":"2023","journal-title":"Virchows Arch"},{"key":"R4-20250414","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1349-7006.2008.01005.x","article-title":"Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin\u2019s lymphoma after rituximab therapy","volume":"100","author":"Maeshima","year":"2009","journal-title":"Cancer Science"},{"key":"R5-20250414","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41591-021-01436-0","article-title":"CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial","volume":"27","author":"Spiegel","year":"2021","journal-title":"Nat Med"},{"key":"R6-20250414","doi-asserted-by":"crossref","first-page":"33487","DOI":"10.18632\/oncotarget.16532","article-title":"Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas","volume":"8","author":"Tsuyama","year":"2017","journal-title":"Oncotarget"},{"key":"R7-20250414","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00428-022-03460-y","article-title":"Chronic lymphocytic leukaemia\/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation","volume":"482","author":"Sander","year":"2023","journal-title":"Virchows Arch"},{"key":"R8-20250414","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41408-024-01146-z","article-title":"Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma","volume":"14","author":"\u00d6zo\u011ful","year":"2024","journal-title":"Blood Cancer J"},{"key":"R9-20250414","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1097\/HS9.0000000000000505","article-title":"CCND1 genomic rearrangement as a secondary event in high grade B-cell lymphoma","volume":"5","author":"Cheng","year":"2021","journal-title":"Hemasphere"},{"key":"R10-20250414","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"key":"R11-20250414","first-page":"2196","article-title":"The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC","volume":"137","author":"Collinge","year":"2021","journal-title":"Blood"},{"key":"R12-20250414","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"R13-20250414","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-20250414","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R15-20250414","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","article-title":"Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements","volume":"6","author":"Frauenfeld","year":"2022","journal-title":"Blood Adv"},{"key":"R16-20250414","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","article-title":"Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"R17-20250414","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"R18-20250414","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"key":"R19-20250414","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"R20-20250414","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J Clin Oncol"},{"key":"R21-20250414","first-page":"2493","article-title":"Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population","volume":"141","author":"Alduaij","year":"2022","journal-title":"Blood"},{"key":"R22-20250414","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Boudov\u00e1","year":"2003","journal-title":"Blood"},{"key":"R23-20250414","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3324\/haematol.2018.203224","article-title":"JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma","volume":"104","author":"Schuhmacher","year":"2019","journal-title":"Haematologica"},{"key":"R24-20250414","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"key":"R25-20250414","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","article-title":"Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"R26-20250414","doi-asserted-by":"crossref","first-page":"e70024","DOI":"10.1002\/hem3.70024","article-title":"Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL","volume":"8","author":"Rivas-Delgado","year":"2024","journal-title":"Hemasphere"},{"key":"R27-20250414","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/leu.2013.348","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma","volume":"28","author":"Kraan","year":"2014","journal-title":"Leukemia"},{"key":"R28-20250414","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/nan.12259","article-title":"Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas","volume":"42","author":"Nakamura","year":"2016","journal-title":"Neuropathology Appl Neurobio"},{"key":"R29-20250414","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"key":"R30-20250414","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41572-023-00439-0","article-title":"Primary central nervous system lymphoma","volume":"9","author":"Ferreri","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"R31-20250414","first-page":"1598","article-title":"The molecular hallmarks of primary and secondary vitreoretinal lymphoma","volume":"6","author":"Bonzheim","year":"2022","journal-title":"Blood Adv"},{"key":"R32-20250414","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","article-title":"High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"150","author":"Pham-Ledard","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R33-20250414","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0000000000001978","article-title":"Intravascular large B-cell lymphoma genomic profile is characterized by alterations in genes regulating NF-\u03baB and immune checkpoints","volume":"47","author":"Gonzalez-Farre","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R34-20250414","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-023-03599-2","article-title":"Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Di Napoli","year":"2023","journal-title":"Virchows Arch"},{"key":"R35-20250414","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/bloodadvances.2020002293","article-title":"Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis","volume":"4","author":"Kaji","year":"2020","journal-title":"Blood Adv"},{"key":"R36-20250414","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/PAS.0000000000001168","article-title":"Age and CD20 expression are significant prognostic factors in human herpes virus-8-negative effusion-based lymphoma","volume":"42","author":"Kubota","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R37-20250414","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2018","journal-title":"Blood"},{"key":"R38-20250414","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00428-022-03427-z","article-title":"Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities","volume":"482","author":"Tousseyn","year":"2023","journal-title":"Virchows Arch"},{"key":"R39-20250414","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.2020009265","article-title":"Taking gray zone lymphomas out of the shadows","volume":"137","author":"Campo","year":"2021","journal-title":"Blood"},{"key":"R40-20250414","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational landscape of gray zone lymphoma","volume":"137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"key":"R41-20250414","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/bloodadvances.2021004515","article-title":"Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified","volume":"5","author":"Bourbon","year":"2021","journal-title":"Blood Adv"},{"key":"R42-20250414","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"R43-20250414","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"R44-20250414","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1200\/JCO.2008.21.5020","article-title":"Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis","volume":"27","author":"Laurent","year":"2009","journal-title":"J Clin Oncol"},{"key":"R45-20250414","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/modpathol.2013.73","article-title":"ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements","volume":"26","author":"Valera","year":"2013","journal-title":"Modern Pathology"},{"key":"R46-20250414","doi-asserted-by":"crossref","first-page":"e18436","DOI":"10.1371\/journal.pone.0018436","article-title":"Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas","volume":"6","author":"Cerchietti","year":"2011","journal-title":"PLoS One"},{"key":"R47-20250414","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"R48-20250414","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"R49-20250414","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3324\/haematol.2020.271957","article-title":"MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma","volume":"106","author":"Ramis-Zaldivar","year":"2021","journal-title":"Haematologica"},{"key":"R50-20250414","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-021-25405-w","article-title":"Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma","volume":"12","author":"Frontzek","year":"2021","journal-title":"Nat Commun"},{"key":"R51-20250414","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/modpathol.2016.233","article-title":"HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma","volume":"30","author":"Gonzalez-Farre","year":"2017","journal-title":"Modern Pathology"},{"key":"R52-20250414","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"key":"R53-20250414","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/cancers13040878","article-title":"Primary effusion lymphoma: a clinicopathological study of 70 cases","volume":"13","author":"Hu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R54-20250414","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12885-021-08215-7","article-title":"Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence","volume":"21","author":"Zanelli","year":"2021","journal-title":"BMC Cancer"},{"key":"R55-20250414","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.2020005470","article-title":"KSHV\/HHV8-mediated hematologic diseases","volume":"139","author":"Cesarman","year":"2022","journal-title":"Blood"},{"key":"R56-20250414","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-022-03404-6","article-title":"Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma","volume":"482","author":"King","year":"2023","journal-title":"Virchows Arch"},{"key":"R57-20250414","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2017-11-764365","article-title":"Critical influences on the pathogenesis of follicular lymphoma","volume":"131","author":"K\u00fcppers","year":"2018","journal-title":"Blood"},{"key":"R58-20250414","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3324\/haematol.2021.279631","article-title":"Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and\/or BCL6 rearrangements characterized by whole-exome sequencing","volume":"107","author":"K\u00fcnstner","year":"2022","journal-title":"Haematologica"},{"key":"R59-20250414","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3324\/haematol.2018.190157","article-title":"Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements is not associated with MYC\/IG gene rearrangements","volume":"103","author":"McPhail","year":"2018","journal-title":"Haematologica"},{"key":"R60-20250414","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/his.12884","article-title":"MYC\/BCL 6 double-hit lymphoma (DHL ): a tumour associated with an aggressive clinical course and poor prognosis","volume":"68","author":"Li","year":"2016","journal-title":"Histopathology"},{"key":"R61-20250414","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R62-20250414","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","article-title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","volume":"2","author":"Chong","year":"2018","journal-title":"Blood Adv"},{"key":"R63-20250414","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00428-021-03050-4","article-title":"The \u201cBurkitt-like\u201d immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS","volume":"479","author":"H\u00fcttl","year":"2021","journal-title":"Virchows Arch"},{"key":"R64-20250414","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/aol-21-18","article-title":"Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants","volume":"5","author":"Rochford","year":"2021","journal-title":"Ann Lymphoma"},{"key":"R65-20250414","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"key":"R66-20250414","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2017-02-767335","article-title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets","volume":"130","author":"Bouska","year":"2017","journal-title":"Blood"},{"key":"R67-20250414","doi-asserted-by":"crossref","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PLoS Pathog"},{"key":"R68-20250414","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood.2023023242","article-title":"SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features","volume":"144","author":"Sureda-G\u00f3mez","year":"2024","journal-title":"Blood"},{"key":"R69-20250414","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humpath.2008.07.021","article-title":"Frequent expression of multiple myeloma 1\/interferon regulatory factor 4 in Burkitt lymphoma","volume":"40","author":"Gualco","year":"2009","journal-title":"Hum Pathol"},{"key":"R70-20250414","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2018-03-842088","article-title":"IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas","volume":"132","author":"Wagener","year":"2018","journal-title":"Blood"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:00:25Z","timestamp":1744614025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000484","relation":{},"ISSN":["1072-4109","1533-4031"],"issn-type":[{"value":"1072-4109","type":"print"},{"value":"1533-4031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]}}}